Literature DB >> 6292982

Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists.

G T Shearman, A Herz.   

Abstract

The purpose of this study was to evaluate the discriminative stimulus properties of some narcotic and non-narcotic drugs in rats trained to discriminate the effect of the proposed opiate kappa-receptor agonists ethylketocyclazocine and bremazocine. Male Sprague-Dawley rats were trained in a two-lever food-reinforced paradigm to discriminate between the effect of ethylketocyclazocine (0.32 mg/kg) or bremazocine (0.04 mg/kg) and saline. Both groups of trained rats showed dose-dependent generalization to the effect of the proposed kappa-agonist MRZ-2033 and some animals generalized the effect of nalorphine and pentazocine. Some ethylketocyclazocine - but no bremazocine - trained rats generalized the effect of buprenorphine. The effect of dextrorphan, phencyclidine, and ketamine was generalized by some bremazocine -, but no ethylketocyclazocine-trained rats. Neither group of rats generalized the effect of etorphine, haloperidol, diazepam, or pentobarbital. These data suggest the usefulness of this procedure to evaluate the kappa-like properties of opioid drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292982     DOI: 10.1007/bf00470590

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  A classification of opiate receptors that mediate antinociception in animals.

Authors:  M B Tyers
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

2.  The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.

Authors:  P E Gilbert; W R Martin
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

3.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

Review 4.  Discriminative stimulus properties of narcotic analgesic drugs.

Authors:  F C Colpaert
Journal:  Pharmacol Biochem Behav       Date:  1978-12       Impact factor: 3.533

5.  Evaluation of the discriminative effects of morphine in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

6.  Demonstration and distribution of an opiate binding site in rat brain with high affinity for ethylketocyclazocine and SKF 10,047.

Authors:  A Pfeiffer; A Herz
Journal:  Biochem Biophys Res Commun       Date:  1981-07-16       Impact factor: 3.575

Review 7.  Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions.

Authors:  S Herling; J H Woods
Journal:  Life Sci       Date:  1981-04-06       Impact factor: 5.037

8.  Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors.

Authors:  G T Shearman; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

9.  Discriminative stimulus properties of bremazocine in the rat.

Authors:  G T Shearman; A Herz
Journal:  Neuropharmacology       Date:  1981-12       Impact factor: 5.250

10.  High affinity binding of [3H]ethylketocyclazocine to rat brain homogenate.

Authors:  D W Harris; V H Sethy
Journal:  Eur J Pharmacol       Date:  1980-08-22       Impact factor: 4.432

View more
  8 in total

1.  Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.

Authors:  K W Locke; B Gorney; M Cornfeldt; S Fielding
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Opioid modulation of the discriminative stimulus produced by pentylenetetrazol.

Authors:  M W Emmett-Oglesby; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor.

Authors:  M J Picker; J Yarbrough
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Discriminative stimulus effects of spiradoline, a kappa-opioid agonist.

Authors:  S G Holtzman; L Cook; G F Steinfels
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 5.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 6.  Drug discrimination by humans compared to nonhumans: current status and future directions.

Authors:  J B Kamien; W K Bickel; J R Hughes; S T Higgins; B J Smith
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.

Authors:  G T Shearman; R Schulz; P W Schiller; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Buprenorphine is an Antagonist at the ϰ Opioid Receptor.

Authors:  M L Richards; W Sadée
Journal:  Pharm Res       Date:  1985-07       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.